Published “Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial” in The Lancet — cited 653 times.
- #crossref
- #research
- #work
Published “Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial” in The Lancet — cited 653 times.
Captured 2026-08-17 from Crossref. The archived copy is preserved so this citation survives link rot.